Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle

BioFactors

Volumn 39, Issue 4, 2013, Pages 467-475

  Painemal, Paula ^b   Acuña, María José ^b   Riquelme, Cecilia ^b   Brandan, Enrique ^b   Cabello Verrugio, Claudio ^a,b  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

AT 2 receptor; Fibrosis; Skeletal muscle; TGF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; SMAD PROTEIN; TGFB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; MALE; MOUSE; MUSCULAR DYSTROPHY; MYOBLAST; MYOFIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CELL LINE; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

MUS;

ANIMALS; CELL LINE; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84881669408     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1087     Document Type: Article

References (50)

1. Border, W. A. and Ruoslahti, E. (1992) Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 90, 1-7.
2. Clouthier, D. E., Comerford, S. A., and Hammer, R. E. (1997) Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J. Clin. Invest. 100, 2697-2713.
3. Sato, M., Muragaki, Y., Saika, S., Roberts, A. B., and Ooshima, A. (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112, 1486-1494.
4. Wrana, J. L. and Attisano, L. (2000) The Smad pathway. Cytokine Growth. Factor. Rev. 11, 5-13.
5. Attisano, L. and Wrana, J. L. (2002) Signal transduction by the TGF-beta superfamily. Science 296, 1646-1647.
6. Cabello-Verrugio, C., Cordova, G., Vial, C., Zuniga, L. M., and Brandan, E. (2011) Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type beta receptors and the JNK pathway. Cell. Signal. 23, 449-457.
7. Morales, M. G., Cabello-Verrugio, C., Santander, C., Cabrera, D., Goldschmeding, R., et al. (2011) CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy. J. Pathol. 225, 490-501.
8. Cabello-Verrugio, C., Morales, M. G., Cabrera, D., Vio, C. P., and Brandan, E. (2012) Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles. J. Cel.l Mol. Med. 16, 752-764.
9. de Gasparo, M. and Siragy, H. M. (1999) The AT2 receptor: fact, fancy and fantasy. Regul. Pept. 81, 11-24.
10. Burson, J. M., Aguilera, G., Gross, K. W., and Sigmund, C. D. (1994) Differential expression of angiotensin receptor 1A and 1B in mouse. Am. J. Physiol. 267, E260-E267.
11. de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., and Unger, T. (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415-472.
12. Basile, D. P. (2000) Is angiotensin II's role in fibrosis as easy as PAI(-1)? Kidney Int. 58, 460-461.
13. Sawada, T., Ishii, Y., Tojimbara, T., Nakajima, I., Fuchinoue, S., et al. (2002) The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice. Pharmacol. Res. 46, 505-510.
14. Li, J. Y., Avallet, O., Berthelon, M. C., Langlois, D., and Saez, J. M. (1999) Transcriptional and translational regulation of angiotensin II type 2 receptor by angiotensin II and growth factors. Endocrinology 140, 4988-4994.
15. Schnee, J. M. and Hsueh, W. A. (2000) Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc. Res. 46, 264-268.
16. Mezzano, S., Droguett, A., Burgos, M. E., Ardiles, L. G., Flores, C. A., et al. (2003) Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int. Suppl.S64-S70.
17. Vio, C. P. and Jeanneret, V. A. (2003) Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases. Kidney. Int. Suppl.S57-S63.
18. Billet, S., Bardin, S., Verp, S., Baudrie, V., Michaud, A., et al. (2007) Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J. Clin. Invest. 117, 1914-1925.
19. Cabello-Verrugio, C., Acuna, M. J., Morales, M. G., Becerra, A., Simon, F., et al. (2011) Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells. Biochem. Biophys. Res. Commun. 410, 665-670.
20. Morales, M., Vazquez, Y., Acuña, M. J., Rivera, J. C., Simon, F., et al. (2012) Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and Transforming Growth Factor beta 1 expression in skeletal muscle cells. Int J. Biochem. Cell Biol. 44, 1993-2002.
21. Ozono, R., Matsumoto, T., Shingu, T., Oshima, T., Teranishi, Y., et al. (2000) Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart. Am. J. Physiol. Regul. Integr. Comp. Physiol 278, R781-R789.
22. Bullock, G. R., Steyaert, I., Bilbe, G., Carey, R. M., Kips, J., et al. (2001) Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem. Cell Biol. 115, 117-124.
23. Leung, P. S., Suen, P. M., Ip, S. P., Yip, C. K., Chen, G., et al. (2003) Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regul. Pept. 116, 61-69.
24. Lijnen, P. and Petrov, V. (1999) Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. Methods Find Exp. Clin. Pharmacol. 21, 363-374.
25. Schiffrin, E. L. (2002) Vascular changes in hypertension in response to drug treatment: effects of angiotensin receptor blockers. Can. J. Cardiol. 18(Suppl A), 15A-18A.
26. Yoshiji, H., Noguchi, R., Ikenaka, Y., Kitade, M., Kaji, K., et al. (2007) Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Curr. Med. Chem. 14, 2749-2754.
27. Tsutsumi, Y., Matsubara, H., Ohkubo, N., Mori, Y., Nozawa, Y., et al. (1998) Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ. Res. 83, 1035-1046.
28. Martin, M. M., Buckenberger, J. A., Jiang, J., Malana, G. E., Knoell, D. L., et al. (2007) TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L790-799.
29. Alvarez, K., Fadic, R., and Brandan, E. (2002) Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy. J. Cell. Biochem. 85, 703-713.
30. Mezzano, V., Cabrera, D., Vial, C., and Brandan, E. (2007) Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2. J. Cell Commun. Signal 1, 205-217.
31. Brandan, E., Cabello-Verrugio, C., and Vial, C. (2008) Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol. 27, 700-708.
32. Bernasconi, P., Di Blasi, C., Mora, M., Morandi, L., Galbiati, S., et al. (1999) Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord. 9, 28-33.
33. Sun, G., Haginoya, K., Wu, Y., Chiba, Y., Nakanishi, T., et al. (2008) Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy. J. Neurol. Sci. 267, 48-56.
34. Sun, G., Haginoya, K., Dai, H., Chiba, Y., Uematsu, M., et al. (2009) Intramuscular renin-angiotensin system is activated in human muscular dystrophy. J. Neurol. Sci. 280, 40-48.
35. Qi, J. S., Minor, L. K., Smith, C., Hu, B., Yang, J., et al. (2005) Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors. Peptides 26, 683-690.
36. Cabello-Verrugio, C., Santander, C., Cofre, C., Acuna, M. J., Melo, F., et al. (2012) The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-beta-dependent signaling, and inhibits TGF-beta-dependentfibrotic response in skeletal muscles. J. Biol. Chem. 287, 6773-6787.
37. Droguett, R., Cabello-Verrugio, C., Santander, C., and Brandan, E. (2010) TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation. Exp. Cell. Res. 316, 2487-2503.
38. Riquelme, C., Larrain, J., Schonherr, E., Henriquez, J. P., Kresse, H., et al. (2001) Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J. Biol. Chem. 276, 3589-3596.
39. Johnston, A. P., Baker, J., Bellamy, L. M., McKay, B. R., De Lisio, M., et al. (2010) Regulation of muscle satellite cell activation and chemotaxis by angiotensin II. PLoS One 5, e15212.
40. Matavelli, L. C., Huang, J., and Siragy, H. M. (2011) Angiotensin AT(2) receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 57, 308-313.
41. Konigshoff, M., Wilhelm, A., Jahn, A., Sedding, D., Amarie, O. V., et al. (2007) The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am. J. Respir. Cell Mol. Biol. 37, 640-650.
42. Ludwig, M., Steinhoff, G., and Li, J. (2012) The regenerative potential of angiotensin AT2 receptor in cardiac repair. Can. J. Physiol. Pharmacol. 90, 287-293.
43. Viswanathan, M. and Saavedra, J. M. (1992) Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides 13, 783-786.
44. Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M., and Inada, M. (1995) Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest. 95, 46-54.
45. Ruiz-Ortega, M., Esteban, V., Suzuki, Y., Ruperez, M., Mezzano, S., et al. (2003) Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int. Suppl.S21-S26.
46. Jin, X. Q., Fukuda, N., Su, J. Z., Lai, Y. M., Suzuki, R., et al. (2002) Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension 39, 1021-1027.
47. Xu, Y., Kumar, D., Dyck, J. R., Ford, W. R., Clanachan, A. S., et al. (2002) AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am. J. Physiol. Heart Circ. Physiol. 282, H1206-H1215.
48. Derynck, R. and Zhang, Y. E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584.
49. Florini, J. R., Roberts, A. B., Ewton, D. Z., Falen, S. L., Flanders, K. C., et al. (1986) Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J. Biol. Chem. 261, 16509-16513.
50. Massague, J., Cheifetz, S., Endo, T., and Nadal-Ginard, B. (1986) Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. U S A 83, 8206-8210.